Global Celiac Disease Pipeline Report 2016 - Review of 13 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Celiac Disease - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Celiac Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Celiac Disease and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Celiac Disease Overview
  3. Therapeutics Development
  4. Pipeline Products for Celiac Disease - Overview
  5. Pipeline Products for Celiac Disease - Comparative Analysis
  6. Celiac Disease - Therapeutics under Development by Companies
  7. Celiac Disease - Therapeutics under Investigation by Universities/Institutes
  8. Celiac Disease Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Celiac Disease - Products under Development by Companies
  13. Celiac Disease - Products under Investigation by Universities/Institutes
  14. Celiac Disease - Companies Involved in Therapeutics Development
  • Alvine Pharmaceuticals, Inc.
  • Amgen Inc.
  • Amyra Biotech AG
  • Avaxia Biologics, Inc.
  • Calypso Biotech SA
  • enGene, Inc
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • ImmusanT, Inc.
  • Innovate Biopharmaceuticals, Inc.
  • Intrexon Corporation
  • Sanofi
  • Zedira GmbH

For more information visit http://www.researchandmarkets.com/research/45f82r/celiac_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Gastrointestinal Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Gastrointestinal Drugs